Yildiz MALDI MS signature for lung cancer
Aliases:This biomarker is also known as:
A serum proteomic signature of seven features identified by MALDI MS has been identified. The serum signature was associated with the diagnosis of lung cancer independently of gender, smoking status, smoking pack-years, and C-reactive protein levels.
|QA State:||Under Review|
There are no datasets associated with this biomarker.